Showing results (141-150 of 274) with videos related to
Sort By:
Pageof 28
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 5, 2026
Apparent diffusion coefficient and kurtosis parameters show early response to anti-angiogenic therapy in patients with colorectal liver metastasesMihaela Rata, Khurum Khan, David J Collins, et al.Clinical Colorectal Cancer|December 10, 2019
Real-world Treatment Patterns and Clinical Outcomes Across Lines of Therapy in Patients With Advanced/Metastatic Gastric or Gastroesophageal Junction CancerDung T Le, Patrick A Ott, Beata Korytowsky, et al.BMC Cancer|February 18, 2016
Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective studySing Yu Moorcraft, Elisa Fontana, David Cunningham, et al.British Journal of Cancer|November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinomaFrancesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.Expert Review of Anticancer Therapy|March 24, 2020
Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international facultyAmitesh C Roy, Jeremy Shapiro, Matt Burge, et al.European Radiology|July 16, 2020
Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding riskNicos Fotiadis, Katja N De Paepe, Lawrence Bonne, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2004
The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancerIan Chau, Mark J Allen, David Cunningham, et al.Clinical Colorectal Cancer|July 8, 2018
Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 PatientsMichael Davidson, Catherine Cafferkey, Emily Frances Goode, et al.European Journal of Haematology|July 22, 2014
Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphomaSarah Barton, Eliza A Hawkes, David Cunningham, et al.Leukemia & Lymphoma|December 10, 2016
Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013Mary Gleeson, Eliza A Hawkes, Clare Peckitt, et al.Pageof 28